CREBBP and sarcoma: To test the effect of CBP/β-catenin disruption on cell proliferation, STS cell lines and primary cultures representing different sarcoma histologies and mutational background were exposed to increasing concentrations of PRI-724 (0.1–50 μM) for 24, 48 and 72 h (Table S1).